Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
6.98
+0.01 (0.14%)
At close: May 12, 2025, 4:00 PM
6.98
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
Lifecore Biomedical Cash Flow Statement
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 23, 2025 | May '24 May 26, 2024 | May '23 May 28, 2023 | May '22 May 29, 2022 | May '21 May 30, 2021 | May '20 May 31, 2020 | 2015 - 2019 |
| Net Income | -44.65 | 12.01 | -99.56 | -116.72 | -32.29 | -38.19 | Upgrade
|
| Depreciation & Amortization | 8.53 | 8.36 | 12.68 | 17.66 | 5.2 | 8.1 | Upgrade
|
| Other Amortization | 0.5 | 0.5 | 0.5 | 0.4 | 3.47 | 10.74 | Upgrade
|
| Loss (Gain) From Sale of Assets | 7.68 | 0.02 | -2.07 | 0.15 | 0.06 | 0.14 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.4 | 1.4 | 0.64 | 5.19 | 10.14 | 27.76 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | 11.47 | 4.2 | Upgrade
|
| Stock-Based Compensation | 9.94 | 6.2 | 3.61 | 2.61 | 3.36 | 2.42 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.26 | 0.26 | 0.16 | -0.01 | 0.94 | -0.28 | Upgrade
|
| Other Operating Activities | 18.39 | -25.13 | 24.53 | -7.25 | -6.84 | -4.54 | Upgrade
|
| Change in Accounts Receivable | -2.58 | -2.39 | 10.82 | -6.14 | 5.78 | -6.36 | Upgrade
|
| Change in Inventory | 5.08 | 0.86 | -14.81 | -2.18 | -2.82 | -12.18 | Upgrade
|
| Change in Accounts Payable | -4.77 | -6.68 | 16.04 | 9.34 | -5.98 | -1.25 | Upgrade
|
| Change in Unearned Revenue | -0.18 | -0.18 | 6.08 | -0.02 | 0.43 | -0.15 | Upgrade
|
| Change in Other Net Operating Assets | 3.08 | 4.54 | 1.66 | -4.11 | 12.36 | -7.45 | Upgrade
|
| Operating Cash Flow | 2.69 | -0.22 | -17.44 | -22.59 | 16.47 | -17.04 | Upgrade
|
| Capital Expenditures | -13.56 | -17.92 | -21.48 | -29.94 | -25.22 | -26.69 | Upgrade
|
| Sale of Property, Plant & Equipment | 7 | - | - | 1.14 | 12.91 | 2.43 | Upgrade
|
| Divestitures | - | - | 16.67 | 73.5 | - | - | Upgrade
|
| Other Investing Activities | - | - | - | 35.26 | - | 0.36 | Upgrade
|
| Investing Cash Flow | -6.56 | -17.92 | -4.81 | 79.96 | -12.31 | -23.89 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 119.3 | Upgrade
|
| Long-Term Debt Issued | - | 149.59 | 181.45 | 75.11 | 270 | 27.5 | Upgrade
|
| Total Debt Issued | 146.48 | 149.59 | 181.45 | 75.11 | 270 | 146.8 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -93.9 | Upgrade
|
| Long-Term Debt Repaid | - | -147.42 | -178.33 | -130.52 | -262.53 | -11.13 | Upgrade
|
| Total Debt Repaid | -164.83 | -147.42 | -178.33 | -130.52 | -262.53 | -105.03 | Upgrade
|
| Net Debt Issued (Repaid) | -18.34 | 2.17 | 3.12 | -55.41 | 7.47 | 41.78 | Upgrade
|
| Issuance of Common Stock | 23.86 | 0.72 | 4.82 | - | - | 0.03 | Upgrade
|
| Repurchase of Common Stock | -1.16 | -0.15 | -0.27 | -0.79 | -0.41 | -0.21 | Upgrade
|
| Other Financing Activities | 1.86 | 4.77 | -6.05 | -0.82 | -10.48 | -1.58 | Upgrade
|
| Financing Cash Flow | 6.21 | 7.51 | 39.7 | -57.02 | -3.42 | 40.02 | Upgrade
|
| Net Cash Flow | 2.34 | -10.63 | 17.45 | 0.35 | 0.74 | -0.91 | Upgrade
|
| Free Cash Flow | -10.87 | -18.14 | -38.92 | -52.53 | -8.75 | -43.73 | Upgrade
|
| Free Cash Flow Margin | -8.34% | -14.14% | -37.69% | -47.21% | -8.68% | -27.32% | Upgrade
|
| Free Cash Flow Per Share | -0.33 | -0.49 | -1.30 | -1.78 | -0.30 | -1.50 | Upgrade
|
| Cash Interest Paid | 2.55 | 2.73 | 31.02 | 16.89 | 13.22 | 10.13 | Upgrade
|
| Cash Income Tax Paid | 0.13 | 0.07 | 0.02 | 0.44 | -7.68 | -1.12 | Upgrade
|
| Levered Free Cash Flow | -27.28 | -19.92 | 16.29 | -26.82 | -7.14 | -43.2 | Upgrade
|
| Unlevered Free Cash Flow | -13.46 | -8.61 | 27.28 | -17.15 | -4.62 | -50.74 | Upgrade
|
| Change in Net Working Capital | 11.37 | 1.26 | -44.3 | 5.77 | -9.86 | 28.97 | Upgrade
|
Updated Jan 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.